Prednisolone as a treatment for chronic active hepatitis
Thornburg, L.P.; Sumerlin, S.
Veterinary Medicine-Small Animal Clinician 76(10): 1435-1436
1981
ISSN/ISBN: 0042-4889 PMID: 6916521 Document Number: 172293
Document emailed within 1 workday
Related Documents
Pár, A.; Paál, M.; Kádas, I.; Kerekes, E.; Jávor, T. 1983: Effect of (+)-cyanidanol-3 (Catergen) in chronic active hepatitis. (Catergen plus prednisolone versus prednisolone in a controlled study) Acta Medica Hungarica 40(1): 17-24Shah, H.A.; Kayani, N.; Sheikh, H.; Jafri, S.W.; Hamid, S.; Khan, A.H. 1995: Comparison of liver histology in chronic active hepatitis C and chronic active hepatitis B Indian Journal of Gastroenterology: Official Journal of the Indian Society of Gastroenterology 14(3): 91-94
Yeh, T.L. 1977: Prednisone and prednisolone in chronic active liver disease American Journal of Hospital Pharmacy 34(9): 920; 922
Sherlock, S. 1977: Diagnosis and treatment of chronic active hepatitis Medical Times 105(4): 83-91; 95-97
Pirotte, J.; Rauber, G.; Ruyters, L. 1972: Chronic persistent hepatitis and chronic active hepatitis. Correlations between the histological aspects, clinical picture, biological and immunological data Archives Francaises des Maladies de l'Appareil Digestif 61(1): 7-18
Pelikán, V.; Seidlová, V.; Sánová, J.; Komenda, S. 1975: Results of immunosuppressive treatment: Prognosis in chronic active hepatitis Acta Hepato-Gastroenterologica 22(4): 210-214
Kouroumalis, E.A.; Koskinas, J. 1986: Treatment of chronic active hepatitis B (CAH B) with chloroquine: a preliminary report Annals of the Academy of Medicine Singapore 15(2): 149-152
Aprosina, Z.G.; Mukhin, A.S. 1972: Treatment of chronic active hepatitis by 6-mercaptopurine and immuran (azathioprine) Sovetskaia Meditsina 35(2): 94-97
Tareev, E.M.; Aprosina, Z.G.; Semendiaeva, M.E.; Traianova, T.G. 1975: Role of immunodepressants in the treatment of chronic active (lupoid) hepatitis Vestnik Akademii Meditsinskikh Nauk SSSR 6: 64-70
Schalm, S.W.; Summerskill, W.H.; Go, V.L. 1977: Prednisone for chronic active liver disease: pharmacokinetics, including conversion to prednisolone Gastroenterology 72(5 Part 1): 910-913
Renner, E.L. 1994: Treatment of autoimmune chronic active hepatitis and of primary biliary cirrhosis Schweizerische Medizinische Wochenschrift 124(12): 495-501
Georgetson, M.J.; Yarze, J.C.; Lalos, A.T.; Webster, G.F.; Martin, P. 1993: Exacerbation of psoriasis due to interferon-alpha treatment of chronic active hepatitis American Journal of Gastroenterology 88(10): 1756-1758
Ouzan, D. 1992: Vidarabine phosphate in the treatment of active chronic hepatitis B. a confirmed hope La Revue du Praticien 42(11): 1383-1386
Aprosina, Z.G.; Krel', P.E.; Eremeeva, E.P. 1985: Treatment of severe forms of chronic active hepatitis with high doses of immunosuppressants Sovetskaia Meditsina 5: 64-68
Tandy, B.; Mark, H.I. 1982: Treatment of the chronic active hepatitis B patient in dental practice: a case study General Dentistry 30(2): 124-127
Spina, M.; Cioffi, D.; Ebreo, A. 1998: Interferon treatment of HCV-correlated active chronic hepatitis and hepatic cirrhosis: personal experience Minerva Gastroenterologica e Dietologica 44(2): 117-120
Juszczyk, J. 1984: Preliminary evaluation of the results of treatment of chronic active hepatitis (HBsAg+) with calf thymus extract (TFX-Polfa) Polski Tygodnik Lekarski 39(33): 1085-1089
Hinoue, Y.; Unoura, M.; Kato, Y.; Kobayashi, K.; Hattori, N. 1984: Effect of interferon on hepatitis B virus infection in patients with chronic active hepatitis Gan to Kagaku Ryoho. Cancer and ChemoTherapy 11(2): 205-211
Galanti, B.; Nardiello, S. 1984: Recent findings concerning the immunopathogenesis of chronic active hepatitis by hepatitis B virus La Ricerca in Clinica e in Laboratorio 14 Suppl. 2: 67-74
Nasonov, E.L.; Burlev, V.A.; Golosova, T.V.; Speranskiĭ, A.I.; Somova, A.V. 1977: Autoimmune component in chronic active hepatitis and its connection with isolation of the hepatitis B surface antigen Terapevticheskii Arkhiv 49(6): 84-89